4BB vs AZN: Side-by-Side Comparison
Compare 4BASEBIO UK SOCIETAS (4BB) and Astrazeneca plc (AZN) side by side: market cap GBX 8.13B vs USD 302.65B. Financials, growth and model signals on Bullrun.
| Metric | 4BB | AZN |
|---|---|---|
| Company | 4BASEBIO UK SOCIETAS | Astrazeneca plc |
| Country / Exchange | United Kingdom · LSE | United Kingdom · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers-General |
| Market cap | GBX 8.13B | USD 302.65B |
| P/E ratio | — | 58.6 |
| Dividend yield | — | 1.63% |
| Valuation model | — | 29.8% overvalued |
| Revenue (latest FY) | GBP 933.00K | — |
| Revenue growth YoY | +84.4% | — |
| Net income | GBP -12.33M | — |
| Gross margin | 67.5% | — |
| Diluted EPS | -0.94 | — |